| Priti Chowdhury, MD | |
|
901 Macarthur Blvd, Attn Anesthesia, Munster, IN 46321-2901 | |
| (219) 836-1600 | |
| (219) 513-1127 |
| Full Name | Priti Chowdhury |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 33 Years |
| Location | 901 Macarthur Blvd, Munster, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255380325 | NPI | - | NPPES |
| 200251370A | Medicaid | IN | |
| 036088620 | Medicaid | IL | |
| 000000081283 | Other | IN | ANTHEM BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 01051S83A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Hospital | Munster, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Munster Medical Research Foundation Inc | 8123913183 | 51 |
News Archive
microDimensions announced today that the United States Patent and Trademark Office has issued the US Patent 2015/0016703 A1 for its method for image registration of sections, in particular of histological sections. The patented technology enables fast and accurate alignment of whole slide and other large images up to the scanned resolution.
A unique Network studying the health and wellbeing of older people is bringing together health, social science and mathematics experts in a revolutionary project which will help shape the long-term provision of health and social care services across the UK and ultimately benefit older people.
The easy accessibility of the eye and the established link between specific genetic defects and ocular disorders offer hope for using gene therapy to provide long-term therapeutic benefit. Two reports in the current issue of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc., describe the effective replacement of a human gene to preserve photoreceptor function in a mouse model of severe retinal degeneration. The articles are available free online.
Spinifex Pharmaceuticals, an Australian pain drug development company, today announced the first patients have been treated in its Phase 2 clinical trial of EMA401 in postherpetic neuralgia (PHN), a painful condition that develops in some patients following herpes zoster (shingles) and where existing therapy does not relieve pain in all individuals.
A new class of drugs called HIF-2 inhibitors is more effective and better tolerated than the standard of care drug sunitinib in treating kidney cancer, researchers with the Kidney Cancer Program at Harold C. Simmons Comprehensive Cancer Center have found.
› Verified 3 days ago
| Entity Name | St Catherine Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396847596 PECOS PAC ID: 1052225604 Enrollment ID: O20031118000149 |
News Archive
microDimensions announced today that the United States Patent and Trademark Office has issued the US Patent 2015/0016703 A1 for its method for image registration of sections, in particular of histological sections. The patented technology enables fast and accurate alignment of whole slide and other large images up to the scanned resolution.
A unique Network studying the health and wellbeing of older people is bringing together health, social science and mathematics experts in a revolutionary project which will help shape the long-term provision of health and social care services across the UK and ultimately benefit older people.
The easy accessibility of the eye and the established link between specific genetic defects and ocular disorders offer hope for using gene therapy to provide long-term therapeutic benefit. Two reports in the current issue of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc., describe the effective replacement of a human gene to preserve photoreceptor function in a mouse model of severe retinal degeneration. The articles are available free online.
Spinifex Pharmaceuticals, an Australian pain drug development company, today announced the first patients have been treated in its Phase 2 clinical trial of EMA401 in postherpetic neuralgia (PHN), a painful condition that develops in some patients following herpes zoster (shingles) and where existing therapy does not relieve pain in all individuals.
A new class of drugs called HIF-2 inhibitors is more effective and better tolerated than the standard of care drug sunitinib in treating kidney cancer, researchers with the Kidney Cancer Program at Harold C. Simmons Comprehensive Cancer Center have found.
› Verified 3 days ago
| Entity Name | Munster Medical Research Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982653044 PECOS PAC ID: 8123913183 Enrollment ID: O20040623000905 |
News Archive
microDimensions announced today that the United States Patent and Trademark Office has issued the US Patent 2015/0016703 A1 for its method for image registration of sections, in particular of histological sections. The patented technology enables fast and accurate alignment of whole slide and other large images up to the scanned resolution.
A unique Network studying the health and wellbeing of older people is bringing together health, social science and mathematics experts in a revolutionary project which will help shape the long-term provision of health and social care services across the UK and ultimately benefit older people.
The easy accessibility of the eye and the established link between specific genetic defects and ocular disorders offer hope for using gene therapy to provide long-term therapeutic benefit. Two reports in the current issue of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc., describe the effective replacement of a human gene to preserve photoreceptor function in a mouse model of severe retinal degeneration. The articles are available free online.
Spinifex Pharmaceuticals, an Australian pain drug development company, today announced the first patients have been treated in its Phase 2 clinical trial of EMA401 in postherpetic neuralgia (PHN), a painful condition that develops in some patients following herpes zoster (shingles) and where existing therapy does not relieve pain in all individuals.
A new class of drugs called HIF-2 inhibitors is more effective and better tolerated than the standard of care drug sunitinib in treating kidney cancer, researchers with the Kidney Cancer Program at Harold C. Simmons Comprehensive Cancer Center have found.
› Verified 3 days ago
| Entity Name | Nwi Medical Associates , Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760182554 PECOS PAC ID: 4183087257 Enrollment ID: O20230823001893 |
News Archive
microDimensions announced today that the United States Patent and Trademark Office has issued the US Patent 2015/0016703 A1 for its method for image registration of sections, in particular of histological sections. The patented technology enables fast and accurate alignment of whole slide and other large images up to the scanned resolution.
A unique Network studying the health and wellbeing of older people is bringing together health, social science and mathematics experts in a revolutionary project which will help shape the long-term provision of health and social care services across the UK and ultimately benefit older people.
The easy accessibility of the eye and the established link between specific genetic defects and ocular disorders offer hope for using gene therapy to provide long-term therapeutic benefit. Two reports in the current issue of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc., describe the effective replacement of a human gene to preserve photoreceptor function in a mouse model of severe retinal degeneration. The articles are available free online.
Spinifex Pharmaceuticals, an Australian pain drug development company, today announced the first patients have been treated in its Phase 2 clinical trial of EMA401 in postherpetic neuralgia (PHN), a painful condition that develops in some patients following herpes zoster (shingles) and where existing therapy does not relieve pain in all individuals.
A new class of drugs called HIF-2 inhibitors is more effective and better tolerated than the standard of care drug sunitinib in treating kidney cancer, researchers with the Kidney Cancer Program at Harold C. Simmons Comprehensive Cancer Center have found.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Priti Chowdhury, MD 901 Macarthur Blvd, Attn Anesthesia, Munster, IN 46321-2901 Ph: (219) 836-7040 | Priti Chowdhury, MD 901 Macarthur Blvd, Attn Anesthesia, Munster, IN 46321-2901 Ph: (219) 836-1600 |
News Archive
microDimensions announced today that the United States Patent and Trademark Office has issued the US Patent 2015/0016703 A1 for its method for image registration of sections, in particular of histological sections. The patented technology enables fast and accurate alignment of whole slide and other large images up to the scanned resolution.
A unique Network studying the health and wellbeing of older people is bringing together health, social science and mathematics experts in a revolutionary project which will help shape the long-term provision of health and social care services across the UK and ultimately benefit older people.
The easy accessibility of the eye and the established link between specific genetic defects and ocular disorders offer hope for using gene therapy to provide long-term therapeutic benefit. Two reports in the current issue of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc., describe the effective replacement of a human gene to preserve photoreceptor function in a mouse model of severe retinal degeneration. The articles are available free online.
Spinifex Pharmaceuticals, an Australian pain drug development company, today announced the first patients have been treated in its Phase 2 clinical trial of EMA401 in postherpetic neuralgia (PHN), a painful condition that develops in some patients following herpes zoster (shingles) and where existing therapy does not relieve pain in all individuals.
A new class of drugs called HIF-2 inhibitors is more effective and better tolerated than the standard of care drug sunitinib in treating kidney cancer, researchers with the Kidney Cancer Program at Harold C. Simmons Comprehensive Cancer Center have found.
› Verified 3 days ago
Dr. Aleksandar Goreski, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 901 Macarthur Blvd, Munster, IN 46321 Phone: 219-703-1443 Fax: 219-513-1127 | |
Diana Shrader, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 901 Macarthur Boulevard, Munster, IN 46321 Phone: 219-836-1600 Fax: 219-513-1127 | |
Stephen E Goldberg, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 901 Macarthur Blvd, Attn Anesthesia, Munster, IN 46321 Phone: 219-836-1600 Fax: 219-513-1127 | |
Diana Cay, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 901 Macarthur Boulevard, Anesthesia Department, Munster, IN 46321 Phone: 219-836-7040 Fax: 219-513-1127 | |
Dr. Kalpana H Doshi, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1650 45th St Ste E, Munster, IN 46321 Phone: 219-595-3369 | |
Brian Mikulan Maxfield, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1928 45th St, Munster, IN 46321 Phone: 219-476-7246 | |
Shariq M Ibrahim, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 8317 Calumet Ave, Munster, IN 46321 Phone: 219-513-2333 Fax: 219-513-2333 |